Bloomios (BLMS) Stock Price

Bloomios Price

OTC·CLOSED
0.00
​
Market closed

Over the last 2 years Bloomios grew revenue by 114.9% annually, reaching 6.08 M USD. For Bloomios, the net margin of -226.7% is down versus -88.9% a few years ago.

Bloomios stock price

Access this data via the Eulerpool API

Bloomios business model & stock analysis

Bloomios, Inc. engages in the manufacture, market, and distribution of U.S. hemp-derived supplements and cosmetic products through wholesale distribution channels and its subsidiary. The company is headquartered in Santa Barbara, California. The company went IPO on 2003-10-14. BPL is engaged in the manufacturing, processing, sourcing and distribution of hemp-derived, nootropic and nutraceutical products to wholesalers and retailers. The firm manufactures hemp infused products ranging from human edibles, pet edibles, liquid consumables such as tinctures and shots, topicals, and smokable hemp. The company provides support at each step from custom formulation, order fulfillment, and brand development. Its product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages and pet treats. The company offers its private-label and white-label customers a collections of customizable hemp products that includes over 80 products across seven categories in addition to custom formulation and manufacturing services.

Frequently asked questions about Bloomios

Converted at the current exchange rate, the Bloomios share trades at 0.00 EUR (0.00 USD).

The revenue cannot currently be calculated for Bloomios.

The profit cannot currently be calculated for Bloomios.

The P/E ratio cannot be calculated for Bloomios at the moment.

The P/S cannot be calculated for Bloomios currently.

The Eulerpool Quality Score for Bloomios is 3/10.

The ISIN of Bloomios is US0948571098. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Bloomios is BLMS. The ticker symbol is used to trade Bloomios shares on the stock exchange.

Fair ValueTerminal
0.00 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue per Employee
202,570.00 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website bloomios.com
Currency
USD
Initial public offering
Oct 14, 2003
ISIN
US0948571098
Cusip
094857109
Market capitalization
19,341.00 USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
—
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-65.29 %
Last updated Oct 10, 2026, 3:41 PM

Bloomios Peer Group

Bloomios Ticker

OTC · BLMSOTC · BLMS

Bloomios FIGI

BLMS:US · BBG000DQYM10BLMS:PQ · BBG000DQYSY1BLMS:UV · BBG000DQYTK4

All fundamentals and in-depth analysis of Bloomios

Our stock analysis for Bloomios stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bloomios. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.